RT @JACCJournals: Background factors in #CardioOnc to consider for #hypertension Tx: 🔸Renal function 🔸TKI use and specific type 🔸White coat…
RT @JACCJournals: Background factors in #CardioOnc to consider for #hypertension Tx: 🔸Renal function 🔸TKI use and specific type 🔸White coat…
RT @JACCJournals: Background factors in #CardioOnc to consider for #hypertension Tx: 🔸Renal function 🔸TKI use and specific type 🔸White coat…
Background factors in #CardioOnc to consider for #hypertension Tx: 🔸Renal function 🔸TKI use and specific type 🔸White coat hypertension A few more in the graphic 👇 Relevant #JACCCardioOnc papers: https://t.co/ovQd6jI523 https://t.co/hsLX4fZxuK #ACCEd #Ca
RT @ACCinTouch: Check out a recent paper #JACCCardioOnc Editor-in-Chief Dr. Bonnie Ky referenced on #bloodpressure elevations in the #Cardi…
RT @ACCinTouch: Check out a recent paper #JACCCardioOnc Editor-in-Chief Dr. Bonnie Ky referenced on #bloodpressure elevations in the #Cardi…
RT @ACCinTouch: Check out a recent paper #JACCCardioOnc Editor-in-Chief Dr. Bonnie Ky referenced on #bloodpressure elevations in the #Cardi…
RT @ACCinTouch: Check out a recent paper #JACCCardioOnc Editor-in-Chief Dr. Bonnie Ky referenced on #bloodpressure elevations in the #Cardi…
RT @ACCinTouch: Check out a recent paper #JACCCardioOnc Editor-in-Chief Dr. Bonnie Ky referenced on #bloodpressure elevations in the #Cardi…
RT @ACCinTouch: Check out a recent paper #JACCCardioOnc Editor-in-Chief Dr. Bonnie Ky referenced on #bloodpressure elevations in the #Cardi…
RT @ACCinTouch: Check out a recent paper #JACCCardioOnc Editor-in-Chief Dr. Bonnie Ky referenced on #bloodpressure elevations in the #Cardi…
RT @ACCinTouch: Check out a recent paper #JACCCardioOnc Editor-in-Chief Dr. Bonnie Ky referenced on #bloodpressure elevations in the #Cardi…
RT @drbrowncares: @CardioOncTrain
RT @ACCinTouch: Check out a recent paper #JACCCardioOnc Editor-in-Chief Dr. Bonnie Ky referenced on #bloodpressure elevations in the #Cardi…
RT @ACCinTouch: Check out a recent paper #JACCCardioOnc Editor-in-Chief Dr. Bonnie Ky referenced on #bloodpressure elevations in the #Cardi…
RT @ACCinTouch: Check out a recent paper #JACCCardioOnc Editor-in-Chief Dr. Bonnie Ky referenced on #bloodpressure elevations in the #Cardi…
RT @ACCinTouch: Check out a recent paper #JACCCardioOnc Editor-in-Chief Dr. Bonnie Ky referenced on #bloodpressure elevations in the #Cardi…
RT @drbrowncares: @CardioOncTrain
@CardioOncTrain
RT @ACCinTouch: Check out a recent paper #JACCCardioOnc Editor-in-Chief Dr. Bonnie Ky referenced on #bloodpressure elevations in the #Cardi…
RT @ACCinTouch: Check out a recent paper #JACCCardioOnc Editor-in-Chief Dr. Bonnie Ky referenced on #bloodpressure elevations in the #Cardi…
Check out a recent paper #JACCCardioOnc Editor-in-Chief Dr. Bonnie Ky referenced on #bloodpressure elevations in the #CardioOnc chat: https://t.co/e4biQf99Ox #TKI https://t.co/7HopdwlRyF
RT @Dr_Mike_Fradley: Highlighted in #ASCO20 #cardioonc talks. Increase in Blood Pressure Associated With Tyrosine Kinase Inhibitors Target…
RT @Dr_Mike_Fradley: Highlighted in #ASCO20 #cardioonc talks. Increase in Blood Pressure Associated With Tyrosine Kinase Inhibitors Target…
RT @Dr_Mike_Fradley: Highlighted in #ASCO20 #cardioonc talks. Increase in Blood Pressure Associated With Tyrosine Kinase Inhibitors Target…
RT @Dr_Mike_Fradley: Highlighted in #ASCO20 #cardioonc talks. Increase in Blood Pressure Associated With Tyrosine Kinase Inhibitors Target…
RT @Dr_Mike_Fradley: Highlighted in #ASCO20 #cardioonc talks. Increase in Blood Pressure Associated With Tyrosine Kinase Inhibitors Target…
RT @Dr_Mike_Fradley: Highlighted in #ASCO20 #cardioonc talks. Increase in Blood Pressure Associated With Tyrosine Kinase Inhibitors Target…
RT @Dr_Mike_Fradley: Highlighted in #ASCO20 #cardioonc talks. Increase in Blood Pressure Associated With Tyrosine Kinase Inhibitors Target…
RT @Dr_Mike_Fradley: Highlighted in #ASCO20 #cardioonc talks. Increase in Blood Pressure Associated With Tyrosine Kinase Inhibitors Target…
RT @Dr_Mike_Fradley: Highlighted in #ASCO20 #cardioonc talks. Increase in Blood Pressure Associated With Tyrosine Kinase Inhibitors Target…
RT @Dr_Mike_Fradley: Highlighted in #ASCO20 #cardioonc talks. Increase in Blood Pressure Associated With Tyrosine Kinase Inhibitors Target…
RT @Dr_Mike_Fradley: Highlighted in #ASCO20 #cardioonc talks. Increase in Blood Pressure Associated With Tyrosine Kinase Inhibitors Target…
RT @Dr_Mike_Fradley: Highlighted in #ASCO20 #cardioonc talks. Increase in Blood Pressure Associated With Tyrosine Kinase Inhibitors Target…
Highlighted in #ASCO20 #cardioonc talks. Increase in Blood Pressure Associated With Tyrosine Kinase Inhibitors Targeting Vascular Endothelial Growth Factor Consider calcium channel blockers. @Ron_Witteles @SWaliany #jacccardioonc https://t.co/GtXU7hrrct
RT @datsunian: @rushiparikh11 @kewatson @gcfmd @Ron_Witteles @Alberta_Yen Thanks Rushi. Cited @Ron_Witteles fascinating study of VEGFi and…
@rushiparikh11 @kewatson @gcfmd @Ron_Witteles @Alberta_Yen Thanks Rushi. Cited @Ron_Witteles fascinating study of VEGFi and the interesting finding of CCB and aldosterone antagonists being more effective at BP control. https://t.co/kZfxGpesEc @StanCVFellow
RT @KNormanPharmD: Adding this to the list of reasons to use spironolactone in #htn #cardioonc https://t.co/aKDYrXEkaB
RT @MariaSolAndres1: All we need to know about HTN related to antiVEGF in #cardiooncology 1)Axitinib generates the biggest increase in BP.…
RT @KNormanPharmD: Adding this to the list of reasons to use spironolactone in #htn #cardioonc https://t.co/aKDYrXEkaB
Adding this to the list of reasons to use spironolactone in #htn #cardioonc https://t.co/aKDYrXEkaB
RT @MariaSolAndres1: All we need to know about HTN related to antiVEGF in #cardiooncology 1)Axitinib generates the biggest increase in BP.…
RT @MariaSolAndres1: All we need to know about HTN related to antiVEGF in #cardiooncology 1)Axitinib generates the biggest increase in BP.…
RT @MariaSolAndres1: All we need to know about HTN related to antiVEGF in #cardiooncology 1)Axitinib generates the biggest increase in BP.…
RT @MariaSolAndres1: All we need to know about HTN related to antiVEGF in #cardiooncology 1)Axitinib generates the biggest increase in BP.…
All we need to know about HTN related to antiVEGF in #cardiooncology 1)Axitinib generates the biggest increase in BP. 2) CCB seem to be the best agents to treat High BP in these cases. 3)the biggest rise in BP occurs during the first 4 weeks of treatment
Last Friday, #JACCCardioOnc Editor-in-Chief Dr. Bonnie Ky presented a R34 clinical trial to mitigate #hypertension seen w/ tyrosine kinase inhbitors (TKI). Revisit the paper on TKIs associated w/ #bloodpressure in the first issue of JACC: Cardio-Oncology:
RT @JACCJournals: Axitinib was found to cause higher systolic & diastolic blood pressures (BP) than other tyrosine kinase inhibitors (TKI).…
RT @CampbellMDPhD: "Anti-VEGF TKIs are associated with increased BP; greatest increases are observed with axitinib. Calcium-channel blocker…
Very Well Explained....
This study quantified the change in blood pressure (BP) during antivascular endothelial growth factor (VEGF) tyrosine kinase inhibitor (TKI) therapy, compared BPs between TKIs, and analyzed change in BP during antihypertensive therapy @JACCJournals https:/
RT @CampbellMDPhD: "Anti-VEGF TKIs are associated with increased BP; greatest increases are observed with axitinib. Calcium-channel blocker…
RT @CampbellMDPhD: "Anti-VEGF TKIs are associated with increased BP; greatest increases are observed with axitinib. Calcium-channel blocker…
"Anti-VEGF TKIs are associated with increased BP; greatest increases are observed with axitinib. Calcium-channel blockers and potassium-sparing diuretic agents were associated with the largest reductions in BP" https://t.co/daeQHsMeZu @sandysrimd @Ron_Witt
This study quantified the change in blood pressure (BP) during antivascular endothelial growth factor (VEGF) tyrosine kinase inhibitor (TKI) therapy, compared BPs between TKIs, and analyzed change in BP during antihypertensive therapy @JACCJournals https:/
RT @aishaikh: Link for the articles ⚡️Prediction system for allograft loss 👉🏽 https://t.co/310OGr4NY2 ⚡️⬆️ K & Met. Acidosis 👉🏽 https://t…
RT @aishaikh: Link for the articles ⚡️Prediction system for allograft loss 👉🏽 https://t.co/310OGr4NY2 ⚡️⬆️ K & Met. Acidosis 👉🏽 https://t…
RT @aishaikh: Link for the articles ⚡️Prediction system for allograft loss 👉🏽 https://t.co/310OGr4NY2 ⚡️⬆️ K & Met. Acidosis 👉🏽 https://t…
RT @aishaikh: Link for the articles ⚡️Prediction system for allograft loss 👉🏽 https://t.co/310OGr4NY2 ⚡️⬆️ K & Met. Acidosis 👉🏽 https://t…
RT @kdjhaveri: Increase in Blood Pressure Associated With Tyrosine Kinase Inhibitors Targeting Vascular Endothelial Growth Factor https://t…
RT @kdjhaveri: Increase in Blood Pressure Associated With Tyrosine Kinase Inhibitors Targeting Vascular Endothelial Growth Factor https://t…
Increase in Blood Pressure Associated With Tyrosine Kinase Inhibitors Targeting Vascular Endothelial Growth Factor https://t.co/YptyPvh0Ns
RT @kdjhaveri: Increase in Blood Pressure Associated With Tyrosine Kinase Inhibitors Targeting Vascular Endothelial Growth Factor https://t…
RT @kdjhaveri: Increase in Blood Pressure Associated With Tyrosine Kinase Inhibitors Targeting Vascular Endothelial Growth Factor https://t…
RT @kdjhaveri: Increase in Blood Pressure Associated With Tyrosine Kinase Inhibitors Targeting Vascular Endothelial Growth Factor https://t…
RT @kdjhaveri: Increase in Blood Pressure Associated With Tyrosine Kinase Inhibitors Targeting Vascular Endothelial Growth Factor https://t…
RT @aishaikh: Link for the articles ⚡️Prediction system for allograft loss 👉🏽 https://t.co/310OGr4NY2 ⚡️⬆️ K & Met. Acidosis 👉🏽 https://t…
RT @aishaikh: Link for the articles ⚡️Prediction system for allograft loss 👉🏽 https://t.co/310OGr4NY2 ⚡️⬆️ K & Met. Acidosis 👉🏽 https://t…
Increase in Blood Pressure Associated With Tyrosine Kinase Inhibitors Targeting Vascular Endothelial Growth Factor https://t.co/p5jOSmSUnB #onconephrology Axitinib was associated with greater SBPs. calcium-channel blockers and potassium-sparing diuretic a
RT @aishaikh: Link for the articles ⚡️Prediction system for allograft loss 👉🏽 https://t.co/310OGr4NY2 ⚡️⬆️ K & Met. Acidosis 👉🏽 https://t…
Link for the articles ⚡️Prediction system for allograft loss 👉🏽 https://t.co/310OGr4NY2 ⚡️⬆️ K & Met. Acidosis 👉🏽 https://t.co/gdognxdY5B ⚡️Oral AC:Afib & kidney dz 👉🏽 https://t.co/ojATAzbaMy ⚡️HTN & Tyrosine Kinase Inhibitors https://t.co/x
RT @Alberta_Yen: Think it's too hard to do impactful research during residency? With good mentorship and opportunities the answer is emphat…
RT @Alberta_Yen: Think it's too hard to do impactful research during residency? With good mentorship and opportunities the answer is emphat…
RT @Alberta_Yen: Think it's too hard to do impactful research during residency? With good mentorship and opportunities the answer is emphat…
RT @Alberta_Yen: Think it's too hard to do impactful research during residency? With good mentorship and opportunities the answer is emphat…
RT @Alberta_Yen: Think it's too hard to do impactful research during residency? With good mentorship and opportunities the answer is emphat…
Think it's too hard to do impactful research during residency? With good mentorship and opportunities the answer is emphatically NO! Congrats to @SWaliany @Ron_Witteles and colleagues on an impt contribution to #CardioOnc @StanfordMedRes
RT @JACCJournals: Axitinib was found to cause higher systolic & diastolic blood pressures (BP) than other tyrosine kinase inhibitors (TKI).…
RT @OncoCard_Ganken: Increase in Blood Pressure Associated With Tyrosine Kinase Inhibitors Targeting Vascular Endothelial Growth Factor htt…
RT @Ron_Witteles: Important takeaways: 1) Anti-VEGF TKIs caused large/rapid BP rises in a real-world setting. 2) Axitinib causes the larges…
RT @Ron_Witteles: Important takeaways: 1) Anti-VEGF TKIs caused large/rapid BP rises in a real-world setting. 2) Axitinib causes the larges…
RT @Ron_Witteles: INCREDIBLE job by @StanfordMedRes PGY-1 @SWaliany leading this ‘big data’ study of real-life BP response to TKIs — publis…
RT @JACCJournals: Axitinib was found to cause higher systolic & diastolic blood pressures (BP) than other tyrosine kinase inhibitors (TKI).…
RT @JACCJournals: Axitinib was found to cause higher systolic & diastolic blood pressures (BP) than other tyrosine kinase inhibitors (TKI).…
RT @JACCJournals: Axitinib was found to cause higher systolic & diastolic blood pressures (BP) than other tyrosine kinase inhibitors (TKI).…
RT @Ron_Witteles: INCREDIBLE job by @StanfordMedRes PGY-1 @SWaliany leading this ‘big data’ study of real-life BP response to TKIs — publis…
RT @Ron_Witteles: Important takeaways: 1) Anti-VEGF TKIs caused large/rapid BP rises in a real-world setting. 2) Axitinib causes the larges…
Thank you to both Dr. Witteles and Dr. Srinivas for their incredible mentorship on this study! Thrilled that the inaugural issue of #JACCCardioOncology is published and am honored for this study to be a part of it. @Ron_Witteles @sandysrimd
RT @Ron_Witteles: Important takeaways: 1) Anti-VEGF TKIs caused large/rapid BP rises in a real-world setting. 2) Axitinib causes the larges…
RT @Ron_Witteles: Important takeaways: 1) Anti-VEGF TKIs caused large/rapid BP rises in a real-world setting. 2) Axitinib causes the larges…
Increase in Blood Pressure Associated With Tyrosine Kinase Inhibitors Targeting Vascular Endothelial Growth Factor https://t.co/Q0tv0yXpB4 #VSPI #VEGF #TKI #hypertension #BPtreatment #CardioOnc #CardioJapan
RT @JACCJournals: Axitinib was found to cause higher systolic & diastolic blood pressures (BP) than other tyrosine kinase inhibitors (TKI).…
Important takeaways: 1) Anti-VEGF TKIs caused large/rapid BP rises in a real-world setting. 2) Axitinib causes the largest increases. 3) Amlodipine was most successful BP treatment - much better than ACE/ARB. 4) Sequential Rx courses raise DBP but not SBP.
RT @JACCJournals: Axitinib was found to cause higher systolic & diastolic blood pressures (BP) than other tyrosine kinase inhibitors (TKI).…
RT @JACCJournals: Axitinib was found to cause higher systolic & diastolic blood pressures (BP) than other tyrosine kinase inhibitors (TKI).…
RT @JACCJournals: Axitinib was found to cause higher systolic & diastolic blood pressures (BP) than other tyrosine kinase inhibitors (TKI).…
RT @JACCJournals: Axitinib was found to cause higher systolic & diastolic blood pressures (BP) than other tyrosine kinase inhibitors (TKI).…
RT @JACCJournals: Axitinib was found to cause higher systolic & diastolic blood pressures (BP) than other tyrosine kinase inhibitors (TKI).…
RT @Ron_Witteles: INCREDIBLE job by @StanfordMedRes PGY-1 @SWaliany leading this ‘big data’ study of real-life BP response to TKIs — publis…
Axitinib was found to cause higher systolic & diastolic blood pressures (BP) than other tyrosine kinase inhibitors (TKI). CCBs & potassium sparing diuretics were associated w/ significant decreases in BP during treatment w/ anti-VEGF TKIs: https://